表紙
市場調査レポート

女性用避妊具の世界市場:2015〜2019年

Global Female Contraceptives Market 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 341164
出版日 ページ情報 英文 73 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
女性用避妊具の世界市場:2015〜2019年 Global Female Contraceptives Market 2015-2019
出版日: 2015年09月30日 ページ情報: 英文 73 Pages
概要

世界の女性用避妊具市場は2014〜2019年にかけCAGR3.0%で拡大すると予測されています。

当レポートでは、世界の女性用避妊具市場の現況と2015〜2019年の成長見通しについて調査し、市場規模、用途別、地域別動向、および主要ベンダーのプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 当レポートの範囲

第3章 市場調査方法

第4章 イントロダクション

第5章 市場環境

第6章 用途別市場セグメンテーション

  • タイプ別世界の女性用避妊具市場
  • 世界の女性用避妊具市場
  • IUD(子宮内避妊具)
  • 避妊手術
  • 皮下インプラント
  • リング
  • 女性用コンドーム
  • 非外科的永久避妊具
  • ペッサリー
  • 避妊スポンジ
  • 避妊薬
  • ピル
  • 緊急ピル

第7章 地域別市場セグメンテーション

  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア太平洋地域

第8章 市場促進因子

第9章 市場促進因子の影響

第10章 市場の課題

第11章 促進因子と課題の影響

第12章 市場動向

第13章 ベンダー環境

  • ベンダーの投資の機会

第14章 他の主要ベンダー分析

第15章 主要ベンダー分析

  • Allergan
  • Merck
  • Pfizer
  • Teva Pharmaceuticals

第16章 付録

第17章 Technavioについて

図表

目次
Product Code: IRTNTR7182

About female contraceptive

Contraception, popularly known as birth control or fertility control, is used to prevent pregnancy. There are various temporary and permanent contraceptive methods and devices available in the market. Sterilization is a permanent method that almost eliminates the chances of pregnancy. Temporary methods can either be hormonal or non-hormonal. Hormonal methods include oral contraceptive pills, contraceptive transdermal patches, vaginal rings, hormonal IUDs, and vaginal implants. These methods use synthetic sex hormones - estrogen, progestin, or a combination of both - to prevent ovulation and thicken the cervical mucus. Non-hormonal methods include condoms, cervical caps, diaphragms, non-hormonal IUDs, sponges, and withdrawal methods.

Technavio's analysts forecast the global female contraceptive market to grow at a CAGR of 3.0% over the period 2014-2019.

Covered in this report

This report covers the present scenario and the growth prospects of the global female contraceptive market for the period 2015-2019. This report considers 2014 as the base year and provides data for the trailing 12 months.

This report covers the following types of female contraceptive:

  • Devices (IUDs, Sterilization, Subdermal contraceptive implants, Vaginal rings, Female condoms, Non-surgical permanent contraception, Contraceptive diaphragms, and Contraceptive sponges)
  • Drugs (Birth control pills and Emergency pills)

Technavio's report, Global Female Contraceptive Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, APAC, and EMEA; it also covers the landscape of the global female contraceptive market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • Allergan
  • Merck
  • Pfizer
  • Teva Pharmaceutical

Other Prominent Vendors

  • Ansell
  • Church & Dwight
  • Bayer
  • Agile Therapeutics
  • Caya
  • Fuji Latex
  • Janssen Pharmaceuticals
  • HLL Lifecare
  • Lipocine
  • Mayer Laboratories
  • Okamoto Industries
  • Reckitt Benckiser Group
  • Today Sponge
  • Female Health

Key market driver

  • Improved family planning
  • For a full, detailed list, view our report

Key market challenge

  • Lack of social acceptance
  • For a full, detailed list, view our report

Key market trend

  • Increased unplanned pregnancy
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Five forces analysis

PART 06: Market segmentation by application

  • Global female contraceptives market by type
  • Global female contraceptive devices market
  • Global IUDs market
  • Global sterilization market
  • Global subdermal contraceptive implants market
  • Global vaginal rings market
  • Global female condoms market
  • Global non-surgical permanent contraceptive devices market
  • Global contraceptive diaphragms market
  • Global contraceptive sponges market
  • Global female contraceptive drugs market
  • Global birth control pills market
  • Global emergency pills market

PART 07: Market segmentation by region

  • Female contraceptives market in Americas
  • Female contraceptives market in EMEA
  • Female contraceptives market in APAC

PART 08: Market drivers

PART 09: Impact of drivers

PART 10: Market challenges

PART 11: Impact of drivers and challenges

PART 12: Market trends

PART 13: Vendor landscape

  • Vendor investment opportunity

PART 14: Analysis of other key vendors

PART 15: Key vendor analysis

  • Allergan
  • Merck
  • Pfizer
  • Teva Pharmaceuticals

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Global female contraceptives market 2014-2019 ($ millions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Global female contraceptives market by type 2014 and 2019
  • Exhibit 05: Global female contraceptives market by type 2014-2019 ($ millions)
  • Exhibit 06: Global female contraceptives market by type 2014-2019
  • Exhibit 07: Global female contraceptives market by devices 2014-2019 ($ millions)
  • Exhibit 08: Global female contraceptive devices market by type 2014 and 2019
  • Exhibit 09: Global IUD's market 2014-2019 ($ millions)
  • Exhibit 10: Global sterilization market 2014-2019 ($ millions)
  • Exhibit 11: Global subdermal contraceptive implants market 2014-2019 ($ millions)
  • Exhibit 12: Global vaginal rings market 2014-2019 ($ millions)
  • Exhibit 13: Global female condoms market 2014-2019 ($ millions)
  • Exhibit 14: Global non-surgical permanent contraceptive devices market 2014-2019 ($ millions)
  • Exhibit 15: Global contraceptive diaphragms market 2014-2019 ($ millions)
  • Exhibit 16: Global contraceptive sponges market2014-2019 ($ millions)
  • Exhibit 17: Global contraceptive drugs by product type
  • Exhibit 18: Global female contraceptive drugs market 2014-2019 ($ millions)
  • Exhibit 19: Global female contraceptives drugs market by type
  • Exhibit 20: Global birth control pills market 2014-2019 ($ millions)
  • Exhibit 21: Global emergency pills market 2014-2019 ($ millions)
  • Exhibit 22: Global female contraceptives by region 2014-2019
  • Exhibit 23: Female contraceptive market in Americas 2014-2019 ($ millions)
  • Exhibit 24: Female contraceptives market in EMEA 2014-2019 ($ millions)
  • Exhibit 25: Female contraceptive market in APAC 2014-2019 ($ millions)
  • Exhibit 26: Effectiveness of female contraception by type
  • Exhibit 27: Impact of drivers
  • Exhibit 28: Impact of drivers and challenges
  • Exhibit 29: Unplanned pregnancies by region 2014-2019 ($ millions)
  • Exhibit 30: Population of women using birth pill for non-contraceptive reasons (%)
  • Exhibit 31: Vendor investment opportunity
  • Exhibit 32: Allergen: Business segmentation 2014
  • Exhibit 33: Allergan: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 34: Pfizer: Business segmentation 2014
  • Exhibit 35: Pfizer: Geographical segmentation 2014
  • Exhibit 36: Teva Pharmaceuticals: Business segmentation 2014
  • Exhibit 37: Teva Pharmaceuticals: Business segmentation by revenue 2013 and 2014 ($ millions)
Back to Top